Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
- Authors
- Westin, J[Westin, Jason]; Olszewski, AJ[Olszewski, Adam J.]; Fogliatto, L[Fogliatto, Laura]; Kim, WS[Kim, Won Seog]; Shin, HJ[Shin, Ho-Jin]; Jeon, YW[Jeon, Young-Woo]; Norasetthada, L[Norasetthada, Lalita]; Pavlovsky, A[Pavlovsky, Astrid]; Rego, E[Rego, Eduardo]; Wu, H[Wu, Hao]; Yin, S[Yin, Shen]; Batlevi, CL[Batlevi, Connie Lee]; Pham, S[Pham, Song]; Penuel, EM[Penuel, Elicia M.]; Jing, J[Jing, Jing]; Wei, MC[Wei, Michael C.]; Budde, LE[Budde, Lihua Elizabeth]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.